Market access is an important part in the chain of approval of a drug and for market success. Here, different target groups learn what they need to know in order to understand relationships, to act professionally correctly and to negotiate in the best possible way. Thanks to his many years of experience, Lothar Flessau can illustrate both the large and the important small connections.
External sales
Basics of statutory health insurance (GKV) - SGB V: Terms and definitions: economic efficiency requirement, drug guidelines and their implementation, test methods
(Expenditure) statistics in the GKV and their (meaning) meanings
Basics and control instruments in statutory health care and agreements a) at the federal level b) at regional (KV) level
Reforms of the health system, including (early) benefit assessment of drugs (AMNOG) and their effects
(Expenditure) statistics in the GKV and their (meaning) meanings
Reforms of the health system, including (early) benefit assessment of drugs (AMNOG) and their effects
Doctors: the doctor in the field of health policy
Doctors who are about to set up a branch or who are planning to do so:
General description of the health policy contexts ("How does the health system work?")
Description and tasks of the partners in self-administration (e.g. KVen and cost bearers, medical service of health insurance (MDK), Federal Joint Committee (G-BA), etc.